News
In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...
As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...
9h
DPA International on MSNEMA recommends approval of additional Alzheimer's treatmentThe European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.
A new study has explored a potential link between a particular sleep pattern and the risk of Alzheimer’s disease ...
"Bleeds on the brain due to high blood pressure, or again, vessel damage. And all of these things, they interrupt the oxygen ...
The AFA opens a new Alzheimer’s support center in Amityville, offering programs, memory screenings and caregiver respite for ...
Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...
Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.
Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...
The combination of a recently approved blood test for detection of Alzheimer's disease combined with two medications that ...
Without the receptor, ADGRG1, the microglia barely nibbled on the toxic protein. Using a mouse model of Alzheimer’s disease, the researchers observed how the loss of ADGRG1 led to the rapid buildup of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results